Ignite Creation Date:
2024-05-06 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 12:23 PM
Study NCT ID:
NCT03134495
Status:
COMPLETED
Last Update Posted:
2017-05-01
First Post:
2017-04-26
Brief Title:
the Impact of Paediatric Use of Proton Pump Inhibitors on the Risk of Community Acquired Infections
Sponsor:
Centre Hospitalier Universitaire Dijon
Organization:
Centre Hospitalier Universitaire Dijon
Study Overview
Official Title:
A Cohort Study to Assess the Impact of Paediatric Use of Proton Pump Inhibitors on the Risk of Community Acquired Infections
Status:
COMPLETED
Status Verified Date:
2017-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
UTOPIE
Brief Summary:
Pharmacological treatment of physiologic Gastro-esophageal Reflux disease GERD is excessive in France as 65-85 of children below 11 years are being treated frequently with Proton Pump Inhibitors PPIs PPI have been associated in adults with an increase of infection rate but data in pediatry are scarce especially in community medecine Recently a study conducted in England brought up controversial results suggesting that the use of PPIs can be associated with a reduced risk of community acquired pneumonia
Our study was aimed to assess on a population-based database the association between PPI prescription and community infections in children of 11 years or under
Our study was aimed to assess on a population-based database the association between PPI prescription and community infections in children of 11 years or under
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None